<p>Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.